Drug Patents owned by Slayback Pharma Llc

1. Drug name - TESTOSTERONE CYPIONATE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11311554 SLAYBACK PHARMA LLC Pharmaceutical compositions of testosterone
Mar, 2039

(16 years from now)

Drugs and Companies using TESTOSTERONE CYPIONATE ingredient

Market Authorisation Date: 02 June, 2022

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
200MG/ML (200MG/ML) SOLUTION;INTRAMUSCULAR Discontinued

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in